ResearcherSichuan UniversityNo recent work listed

Ye Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7964-7899; OpenAlex author ID A5100359113. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network meta-analysis of randomized controlled tria… Co-author DOI 10.1097/md.0000000000015761 ↗
Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients. Co-author DOI 10.1007/s12013-014-0345-2 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qiancheng Hu · 1 shared paper, 2019 · strength 0.11
- Paper Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network met… DOI 10.1097/md.0000000000015761 ↗
Peng Cao · 1 shared paper, 2019 · strength 0.11
- Paper Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network met… DOI 10.1097/md.0000000000015761 ↗
Dan Cao · 1 shared paper, 2019 · strength 0.11
- Paper Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network met… DOI 10.1097/md.0000000000015761 ↗
Xiaoshan Feng · 1 shared paper, 2015 · strength 0.05
- Paper Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Ca… DOI 10.1007/s12013-014-0345-2 ↗
Shegan Gao · 1 shared paper, 2015 · strength 0.05
- Paper Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Ca… DOI 10.1007/s12013-014-0345-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.